...
首页> 外文期刊>Medical science monitor : >Changes in Plasma PPARs Levels in Migraine Patients
【24h】

Changes in Plasma PPARs Levels in Migraine Patients

机译:偏头痛患者血浆PPARs水平的变化

获取原文
           

摘要

BACKGROUND The aim of this study was to observe the change in plasma PPARs (peroxisome proliferator-activated receptors) level during various periods and in different subtypes in migraine patients. MATERIAL AND METHODS We divided 227 patients with migraine into 2 main groups: the attack period group (n=98) and the attack-free period group (n=129). Patients were further divided into 4 subgroups according to whether they had aura symptoms. The control group consisted of 100 healthy subjects. We collected the clinical data of patients and measured the plasma levels of PPARs using enzyme-linked immunoassay (ELISA). We used SPSS software for statistical analysis. RESULTS We found no significant difference in age, BMI, blood pressure, or blood lipid level among migraine patients during the headache attack period and during the headache-free period compared with the control group. The PPARα and PPARβ/δ levels during the headache attack period were significantly higher than during the headache free period and in healthy controls. The PPARγ levels during the headache attack period were significantly lower than those during the headache-free period and in the healthy control group. The PPARs levels during the headache attack period were significantly different from those during the headache-free period, regardless of presence or absence of aura. The PPARs levels during the headache-free period were not significantly different from those of the healthy control group. The level of PPARs has no significant differences between migraine with aura group and without aura group, regardless of whether headache attack. CONCLUSIONS PPARs involved in the pathogenesis of migraine. Presence of absence of aura had no obvious effect on PPARs level.
机译:背景技术本研究的目的是观察偏头痛患者在不同时期和不同亚型中血浆PPAR(过氧化物酶体增殖物激活受体)水平的变化。材料与方法我们将227例偏头痛患者分为两个主要组:发作期组(n = 98)和无发作期组(n = 129)。根据患者是否有先兆症状将其进一步分为4个亚组。对照组由100名健康受试者组成。我们收集了患者的临床数据,并使用酶联免疫法(ELISA)测量了PPAR的血浆水平。我们使用SPSS软件进行统计分析。结果我们发现偏头痛患者在头痛发作期和无头痛期的年龄,BMI,血压或血脂水平与对照组相比无显着差异。头痛发作期的PPARα和PPARβ/δ水平显着高于无头痛期和健康对照组。头痛发作期的PPARγ水平明显低于无头痛期和健康对照组的PPARγ水平。不论有无先兆,头痛发作期的PPARs水平与无头痛期的PPARs水平显着不同。无头痛期的PPARs水平与健康对照组无显着差异。有先兆组的偏头痛和没有先兆组的偏头痛之间的PPARs水平无显着差异,无论是否发作头痛。结论PPARs参与偏头痛的发病机制。不存在先兆对PPARs水平无明显影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号